Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
This report contains market size and forecasts of Amebiasis Drugs in global, including the following market information:
- Global Amebiasis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Amebiasis Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Amebiasis Drugs companies in 2021 (%)
The global Amebiasis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metronidazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amebiasis Drugs include Dr. Reddy?s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals and Glenmark Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amebiasis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amebiasis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Amebiasis Drugs Market Segment Percentages, by Type, 2021 (%)
- Metronidazole
- Paromomycin
- Tinidazole
- Other
Global Amebiasis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Amebiasis Drugs Market Segment Percentages, by Application, 2021 (%)
Global Amebiasis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Amebiasis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Amebiasis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Amebiasis Drugs revenues share in global market, 2021 (%)
- Key companies Amebiasis Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Amebiasis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Dr. Reddy?s Laboratories
- Mission Pharmacal
- Aceto Corporation
- Mylan Pharmaceuticals
- Impax Laboratories
- Pfizer
- Sanofi
- Lupin Pharmaceuticals
- Glenmark Pharmaceuticals
- Sun Pharmaceutical
- Heritage Pharmaceuticals
